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Craniomaxillofacial fibrous dysplasia: a 10-year database
1996-2006
Abstract
Fibrous dysplasia is a rare bone disease caused by an abnormal proliferation of fibrous tissue in bone.
We retrospectively evaluated eight patients (female to male ratio 3:1, mean age 22.5 years, range 10-32)
with a monostotic form who were treated between 1996 and 2006. Two each were affected in the lower
jaw, the upper jaw, the midface, and the frontoparietal region. Most patients were referred because of a
painless swelling. Biopsy specimens from two patients were examined, six patients had modelling
osteotomies, two of whom had further operations because of progressive enlargement. There was no
visual impairment or malignant transformation. Fibrous dysplasia should be treated as conservatively as
possible, but in cases of functional disturbance that results from malignant transformation, or from the
involvement of the optic foramen or the foramen magnum, an immediate operation is needed.
Disfigurement can be another reason for operation. When there is a risk of malignant transformation,
follow-up of patients is recommended.
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Abstract 
Fibrous dysplasia is a rare bone disease caused by an abnormal proliferation of 
fibrous tissue in bone. 
We retrospectively evaluated eight patients (female-male ratio: 3:1, mean age 22,5 
years, range 10-32) with a monostotic form who were treated between 1996 – 2006 
Two each were affected in the lower jaw, the upper jaw, the midface, and the 
frontoparietal region.  
Most patients were referred because of a painless swelling. Biopsy specimens from 
two patients were examined six patients had modeling osteotomies, two of whom had 
further operations because of progressive enlargement. There was no visual 
impairment or malignant transformation.  
Fibrous dysplasia should be treated as conservatively as possible, but in cases of 
functional disturbance results from malignant transformation, or from the involvement 
of the optic foramen or the foramen magnum, an immediate operation is needed. 
Disfigurement can be another reason for operation.  
When there is a risk of malignant transformation, follow-up of patients is 
recommended. 
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Introduction 
The term fibrous dysplasia was first mentioned by Lichtenstein in 1938.1 It is a rare 
localized disease often associated with bony deformities caused by the abnormal 
proliferation of fibrous tissue interspersed with normal or immature bone because of 
poorly differentiated, mutated osteoblasts. Some authors suggest that greater 
resorption of bone in affected areas2,3 is because of the activation of Gsα and 
increased synthesis of IL6, a cytokine involved in the differentiation of osteoclasts.2,4   
Fibrous dysplasia is found in 3% of all bony tumours and in over 7% of all non-
malignant tumours of bone.5,6  
Malignant change is rare, roughly 0,5% for the monostotic form and 4% for McCune-
Albright syndrome.7,8 Yabut et al6 and identified reports of 83 cases (27 in facial 
bones) of malignant degeneration in fibrous dysplasia; osteosarcoma was the most 
common, followed by fibrosarcoma, and chondrosarcoma. Malignant transformations 
were found mostly in the third or fourth decade of life. It is important to note that 28% 
of these transformations were in patients who had had fibrous dysplasia lesions 
radiated. 
This disease can be divided into subtypes: roughly 70% are monostotic, roughly 30% 
are polyostotic. It is also found in McCune-Albright syndrome (an association of 
fibrous dysplasia), precocious puberty, endocrine abnormalities, and pigmented 
cutaneous lesions in female patients. There seems to be no transition from one form 
to the other. Fries found that the skull was involved in 28 patients (72%) with a 
polyostotic form and in 11 (28%) with a monostotic form.9 The fronto-orbital region 
was affected in 20% of patients.10  
Differential diagnosis includes Paget disease, osteofibrous dysplasia, ossifying 
fibroma, and sarcoma. The most useful diagnostic sign to fibrous dysplasia from 
Paget disease is a ground glass bony matrix seen on a bone window on a computed 
tomogram (CT) (Fig. 1) and caused by the admixture of fibrous and osseous 
elements.  Thin cortical tables, involvement of the orbit, nasal cavity, and maxilla are 
also signs of fibrous dysplasia.11  
Maki et al12 retrospectively studied 90 cases of fibrous dysplasia and 17 of 
osteofibrous dysplasia. Osteofibrous dysplasia occurred only in the tibia or fibula. The 
mean age of those with fibrous dysplasia was 24 years, compared with that of 
patients with osteofibrous dysplasia, which was 12.9 years.  
We retrospectively evaluated eight patients (female to male ratio 3:1, mean age 22.5 
years, range 10-32) with a monostotic form who were treated between 1996 and 
2006.  
 
 
Fig1: Typical “ground glass” matrix and enlargement 
of the frontal bone in the CT 
 
Patients 
Eight patients were referred to the Department of Cranio-Maxillofacial Surgery at the 
University Hospital, Zurich between 1996 and 2006. The female to male ratio was 
3:1, mean age 22,5 years (range 10-32). 
Details about the patients’ age, sex, clinical presentation, radiological extent of 
tumour, histopathology, microcomputed tomography (micro-CT), and treatment are 
shown in Table 1. 
                    
Fig 2:bony enlargement on the left side of the lower jaw               Fig 3: bony enlargement on the left side of the upper jaw 
 
distribution of localisation
frontoparietal
25%
upper jaw
25%
lower jaw
25%
middleface
25%
 
Table 1: distribution of localisation 
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Treatment 
  Fig 5:intraoperative view 
Sex Age 
(years) 
Site of lesion First symtoms Date of 
operation 
Operation 
F 9 Right lower jaw  Bony cyst as additional diagnostic 
finding in Orthopantomogram 
8/18/06 Modeling osteotomy 
F 10 Right lower jaw Painless bony enlargement 1/20/04 Modeling osteotomy 
F 1 Left upper jaw Painless bony enlargement 5/7/03 Modeling osteotomy 
F 20 Left upper jaw Additional diagnostic finding  5/15/06 Biopsy 
F 32 Right midface Asymmetry of the midface 5/15/02 Modeling osteotomy 
M 32 Left midface Painless swelling upper jaw, slight 
exophthalmus, slight  infraorbital 
hyposensibility  
2/27/91 
4/16/96 
5/20/98 
2/27/00 
Modeling osteotomy 
Modeling osteotomy lateral canthopexia 
Genioplasty, lateral canthopexia  
Modeling osteotomy 
F 32 Right temporal Painless preauricular swelling  10/31/01 Biopsy  
M 32 Right frontoparietal  Supraorbital asymmetry 12/20/00 
11/27/01 
11/18/03 
12/7/05 
Modeling osteotomy, calvarial remodeling 
Calvaria remodeling 
Calvaria remodeling 
Calvaria remodeling 
Table 2: summary of the patients 
 
Seven of eight patients were referred because of a painless swelling or asymmetry 
(Fig.2 and 3), and one of a suspected bony cyst. Biopsy specimens were taken in two 
cases (Fig 4). Six patients had modeling osteotomies, two of whom had further 
operations: bimaxillary osteotomy and calvarial remodeling. 
The histological findings of all patients were similar with features of osseous and 
fibrous lesions. The osseous component consisted of trabeculae of woven bone with 
eminating collagen fibers. The trabeculae lacked an osteoblastic rimming. Bland 
spindle cells with no mitotic figures were interspersed. There were no definable 
borders (Fig 5). 
 
Figure 6: Fibrous-osseous lesion with trabeculae of woven bone and interosseous spindle cells, H&E, x50. 
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Figure 7: Woven bone with eminating collagen fibers (arrow), EvG, x100.  
 
The bony samples (0.5 cm) with fibrous dysplasia were examined with a SkyScan 
1172 microcomputer tomograph (Skyscan, Kontich, Belgium) using a fan beam. 
Images were obtained with an aluminium filter and reconstructed with a three-
dimensional DICAM medical viewer (Osirix®). The trabecular structure is partly not 
recognisable because the bone has been remodelled (Fig. 6a and b).  
 
Fig 8a: fibrous dysplasia with disintegrated trabecular structure     Fig 8b: same sample with higher translucency  
 
Discussion 
Opinions about treatment range from various surgical methods to medical treatment 
such as pamidronate given intravenously,13,14 but it is clear that a conservative 
approach may not be suitable in all cases of craniofacial fibrous dysplasia. 
Pamidronate 60mg/day given intravenously on 3 successive days to reduce 
osteoclastic activity has been given every 6 months for 18 months. It resulted in a 
decreasing intensity of bony pain, reduced bony resorption, and improved 
radiological features such as filling of lytic lesions in about half of the patients.14  
The use of calcitonin is not supported universally; some authors report good 
results,15  while others report poor.16,17 
We recommend that vitamin D and calcium supplements are given because 
concentrations of serum calcium are low.3 
Many factors have to be considered when deciding about further treatment. One is  
the aesthetic implication for the patient, but functional impairment should take 
precedence. 
In thinner bone, such as the orbital plate of the maxillary, ethmoid and frontal bones, 
the cortex expands more rapidly and to a greater degree than in thicker cortical 
bone.19 When the orbit is involved compression and subsequent distortion of the 
globe can cause errors in refraction, focusing, and accommodation,20 so immediate 
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removal of the dysplastic process and decompression of the optic nerve canal is 
necessary. Visual loss in fibrous dysplasia is caused by the progressive compression 
of venous drainage of the optic nerve, which leads to reduced retinal perfusion.21   
Operation is also essential when the foramen magnum is affected to prevent life-
threatening conditions. 
Chen and Noordhoff based surgical treatment on four areas of involvement: excision 
of dysplastic bone and reconstruction with autogenous bone graft in the fronto-orbit, 
nasal ethmoid and upper maxilla, or the conservative shaving of the parietal and part 
of the occipital bone.  
Orthognathic operations can be done to restore occlusion and correct disproportion 
of the jaw when tooth-bearing bone is involved. Yeow and Chen23 we achieved long-
term stability of the occlusion in one of our patients. 
The risk of developing sarcoma is 400times higher in patients who have been treated 
previously with radiation than in non-radiated patients. Radiotherapy should not be 
used to treat fibrous dsysplasia.5 When there is a risk of malignant degeneration 
follow-up of these patients is recommended. Schwarz and Alpert24 found that there 
was a mean interval of 13.5 years between diagnosis of fibrous dysplasia and the 
development of malignancy.  
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Fig1: typical “groundglass” matrix and enlargement 
of the frontal bone in the CT 
                   
Fig 2:bony enlargement on the left side of the lower jaw               Fig 3: bony enlargement on the left side of the upper jaw 
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  Fig 5:intraoperative view 
sex age 
(y) 
location side first symtoms visual 
impair
ment 
date of 
surgery 
kind of surgery malig
n. 
transf
or. 
f 9 lower jaw  right “bone cyst” as additional 
diagnostic finding in OPT 
no 8/18/06 modeling osteotomy no 
f 10 lower jaw right painless bony enlargement no 1/20/04 modeling osteotomy no 
f 13 upper jaw left painless bony enlargement no 5/7/03 modeling osteotomy no 
f 20 upper jaw left additional diagnostic finding  no 5/15/06 biopsy no 
f 32 middle face right asymmetry of the middle face no 5/15/02 modeling osteotomy no 
m 32 middle face left painless swelling upper jaw, slight 
exopthalmus, slight  hyposensibiliy 
infraorbital 
no 2/27/91 
4/16/96 
 
5/20/98 
2/27/00 
modeling osteotomy 
modeling osteotomy, lat. 
kanthopexia 
bimax.osteotomy, 
genioplastic, lat.kanthopexia 
modeling osteotomy 
no 
f 32 temporal right painless swelling preauricular no 10/31/01 biopsy  no 
m 32 frontoparietal  right asymmetry supraorbital no 12/20/00 
11/27/01 
11/18/03 
12/7/05 
modeling osteotomy, calvaria 
remodeling 
calvaria remodeling 
calvaria remodeling 
calvaria remodeling 
no 
Table 2: summary of the patients 
  1
 Figure 6: Fibrous-osseous lesion with trabeculae of woven bone and interosseous spindle cells, H&E, x50. 
 
 
Figure 7: Woven bone with eminating collagen fibers (arrow), EvG, x100.  
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